Sofinnova Partnersand Fondazione Telethon present this new joint initiative aimed at funding and/or creating Italian biotech start-ups in the field of rare and/or genetic diseases with an investment of up to 1,5M€.
The third edition of G-Factor is coming with new opportuinities for teams, startups and spinoffs.
For this third edition G-Factor confirms the investments and acceleration program for Life Science & Digital Health startups and it opens two other sectors with the I-Tech Innovation 2021 program, thanks to the partnership between the Golinelli Foundation and CRIF.
The 4th Edition of the Call for Solutions by Open Accelerator, international acceleration program for Life Science's star-up, created by Zcube - Zambon Research Ventur in open until the 20th July
A new decree has been approved by the Italian Government about the corporate investment on innovation. These incentives can create new opportunities and new collaborations between academia and companies.
Since the beginning of COVID-19 pandemic SISSA scientists have been working at different levels to help understanding the virus, finding new therapies and developing strategies to contain its diffusion. Here are some of the ongoing projects.
The SISSA Alumni Society is organizing this series of seminars for fellow alumni. It would like to be a moment of sharing of stories and experiences. What are they doing? What was the path that led them where they are now?
To join the webinars and know more about the speaker click here
